Ningbo Menovo Pharmaceutical Co.Ltd(603538) : reply from the controlling shareholder and actual controller on the inquiry letter on abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading Ningbo Menovo Pharmaceutical Co.Ltd(603538) : the inquiry letter on abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading issued by the capital company has been received. After careful verification, the reply is as follows: after consulting the opinions of the actual controller, as of the date of this letter, Mr. Yao Chengzhi, the actual controller, has no major events affecting the abnormal fluctuation of the stock trading price of Ningbo Menovo Pharmaceutical Co.Ltd(603538) (hereinafter referred to as ” Ningbo Menovo Pharmaceutical Co.Ltd(603538) “), and there are no major events that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring Major events such as arrival and departure of assets and asset injection; There is no trading of the company’s shares during abnormal stock fluctuations. As the controlling shareholder of Ningbo Menovo Pharmaceutical Co.Ltd(603538) Ningbo Ningbo Menovo Pharmaceutical Co.Ltd(603538) Holding Group Co., Ltd., as of the date of this letter, there are no major events affecting the abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading price, and there are no major events that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring, asset arrival and departure, asset injection and other major events; There is no trading of the company’s shares during abnormal stock fluctuations. Hereby reply (no text below)
© China Stock Market News